Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 4,348 shares at $33.75 ($146K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Open-market sale of $146k RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.70 | 1,152 | $38K | 25.9% |
| 2 | $33.75 | 1,598 | $54K | 37.1% |
| 3 | $33.75 | 1,598 | $54K | 37.1% |
| Total | $33.47 avg | 4,348 | $146K | 100% |
| Filing → |
| RGNX | SELL | 2026-05-13 | $169K | — | Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |